Health and Healthcare

Regeneron : REGN

All Regeneron Articles

247 Articles

Chris Lange | Nov 5, 2020 at 10:35 AM EST

Is Regeneron Making the Case to Buy With Q3 Earnings?

Regeneron Pharma reported its third-quarter financial results before the markets opened on Thursday.

Chris Lange | Nov 1, 2020 at 6:10 AM EST

GM, PayPal, Qualcomm, Regeneron, Uber and More Major Earnings Coming This Week

24/7 Wall St. has put together a preview of the most prominent earnings reports this week, including General Motors, T-Mobile…

Jon C. Ogg | Oct 28, 2020 at 7:01 PM EDT

Did Regeneron Just Revive Hopes About Beating COVID-19?

The novel coronavirus has wiped out trillions of dollars in global output with more than 1 million deaths worldwide in…

Chris Lange | Oct 27, 2020 at 9:55 AM EDT

Major Biotechs Have Short Sellers Looking Both Ways

The October 15 short interest data has been compared with the previous report, and short interest moves in these selected…

Jon C. Ogg | Oct 20, 2020 at 8:04 AM EDT

13 Companies That Should Consider Stock Splits This Earnings Season

Here are 13 other companies that should seriously entertain splitting their stocks. Splits are of course a gimmick, but the…

Chris Lange | Oct 17, 2020 at 8:40 AM EDT

7 Large Biotechs Expected to Outperform This Earnings Season

Earnings season is upon us and investors are pining for information about which stocks and sectors will do well. After…

Chris Lange | Oct 12, 2020 at 10:03 AM EDT

Short Sellers Need to Find a Clue on Major Biotechs

The September 30 short interest data has been compared with the previous report, and short interest moves in these selected…

Jon C. Ogg | Oct 6, 2020 at 8:57 AM EDT

Top Analyst Upgrades and Downgrades: Alexion, Bill.com, Boeing, Costco, Generac, Proofpoint, Regeneron, Shopify and More

Tuesday's top analyst upgrades and downgrades included Alexion Pharmaceuticals, Bill.com, Boeing, Costco, Dicks Sporting Goods, Generac, Proofpoint, Regeneron Pharmaceuticals and…

Jon C. Ogg | Oct 5, 2020 at 1:28 PM EDT

Are President Trump’s COVID-19 Drugs the Real Winners in the Race?

Many health care products become much more popular because of endorsements and advertising efforts. It is a longstanding practice that…

Jon C. Ogg | Oct 5, 2020 at 9:09 AM EDT

Top Analyst Upgrades and Downgrades: Amex, AT&T, CRISPR, DocuSign, ONEOK, Regeneron, Shopify, Tesla and More

Monday's top analyst upgrades and downgrades included American Express, AT&T, CRISPR Therapeutics, DocuSign, ONEOK, Regeneron Pharmaceuticals, Shopify and Tesla.

Chris Lange | Sep 30, 2020 at 9:22 AM EDT

2 Big Positive Developments in the COVID-19 Vaccine Race

Moderna and Regeneron Pharmaceuticals each announced positive news late on Tuesday about their respective COVID-19 vaccine trials.

Chris Lange | Sep 25, 2020 at 9:54 AM EDT

Biotech Short Sellers Hike Their Bets

The September 15 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Sep 19, 2020 at 9:26 AM EDT

This Week in Coronavirus News

As an approved COVID-19 vaccine nears completion in terms of clinical trials, what can we expect? In the past couple…

Chris Lange | Sep 11, 2020 at 10:05 AM EDT

Short Sellers Hike Their Bets in Major Biotechs

The August 31 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Sep 10, 2020 at 7:55 AM EDT

5 Very Undervalued Large Cap Biotech Stocks That Could Explode in 2021

Practically any biotech company attempting almost anything COVID-19 related has seen massive gains. However, there is likely more to come…

1 2 3 4 5 6 … 17

Regeneron : REGN

All Regeneron Articles

Is Regeneron Making the Case to Buy With Q3 Earnings?

GM, PayPal, Qualcomm, Regeneron, Uber and More Major Earnings Coming This Week

Did Regeneron Just Revive Hopes About Beating COVID-19?

Major Biotechs Have Short Sellers Looking Both Ways

13 Companies That Should Consider Stock Splits This Earnings Season

7 Large Biotechs Expected to Outperform This Earnings Season

Short Sellers Need to Find a Clue on Major Biotechs

Top Analyst Upgrades and Downgrades: Alexion, Bill.com, Boeing, Costco, Generac, Proofpoint, Regeneron, Shopify and More

Are President Trump’s COVID-19 Drugs the Real Winners in the Race?

Top Analyst Upgrades and Downgrades: Amex, AT&T, CRISPR, DocuSign, ONEOK, Regeneron, Shopify, Tesla and More

2 Big Positive Developments in the COVID-19 Vaccine Race

Biotech Short Sellers Hike Their Bets

This Week in Coronavirus News

Short Sellers Hike Their Bets in Major Biotechs

5 Very Undervalued Large Cap Biotech Stocks That Could Explode in 2021

Uber and DoorDash Drivers Think They Have No 401(k). The IRS Lets Them Build a $72,000 One but Almost Nobody Does

I’d Put $25,000 in These 2 ETFs Before the Next Earnings Season

The $111,000 Tax-Free Giving Strategy Retirees Are Missing in 2026

Uber and DoorDash Drivers Think They Have No 401(k). The IRS Lets Them Build a $72,000 One but Almost Nobody Does

The $111,000 Tax-Free Giving Strategy Retirees Are Missing in 2026

Uber and DoorDash Drivers Think They Have No 401(k). The IRS Lets Them Build a $72,000 One but Almost Nobody Does

I’d Put $25,000 in These 2 ETFs Before the Next Earnings Season

Regeneron : REGN

All Regeneron Articles

Is Regeneron Making the Case to Buy With Q3 Earnings?

GM, PayPal, Qualcomm, Regeneron, Uber and More Major Earnings Coming This Week

Did Regeneron Just Revive Hopes About Beating COVID-19?

Major Biotechs Have Short Sellers Looking Both Ways

13 Companies That Should Consider Stock Splits This Earnings Season

7 Large Biotechs Expected to Outperform This Earnings Season

Short Sellers Need to Find a Clue on Major Biotechs

Top Analyst Upgrades and Downgrades: Alexion, Bill.com, Boeing, Costco, Generac, Proofpoint, Regeneron, Shopify and More

Are President Trump’s COVID-19 Drugs the Real Winners in the Race?

Top Analyst Upgrades and Downgrades: Amex, AT&T, CRISPR, DocuSign, ONEOK, Regeneron, Shopify, Tesla and More

2 Big Positive Developments in the COVID-19 Vaccine Race

Biotech Short Sellers Hike Their Bets

This Week in Coronavirus News

Short Sellers Hike Their Bets in Major Biotechs

5 Very Undervalued Large Cap Biotech Stocks That Could Explode in 2021

Uber and DoorDash Drivers Think They Have No 401(k). The IRS Lets Them Build a $72,000 One but Almost Nobody Does

I’d Put $25,000 in These 2 ETFs Before the Next Earnings Season

The $111,000 Tax-Free Giving Strategy Retirees Are Missing in 2026

Featured Reads

Uber and DoorDash Drivers Think They Have No 401(k). The IRS Lets Them Build a $72,000 One but Almost Nobody Does

The $111,000 Tax-Free Giving Strategy Retirees Are Missing in 2026